Category Archives: Tms

DataIntelo has published a latest report on Global TMS(Transcranial Magnetic Stimulation) Coil Market report. This report has been prepared by primary interviews and secondary research methodology. The market report provides detailed insights on the product pricing & trends, market drivers, and potential lucrative opportunities, during the forecast period, 2020-2027. Additionally, it covers market challenges and threats faced by companies.

Competitive Landscape

The market report provides information about the companys product, sales in terms of volume and revenue, technologies utilized, and innovations carried out in recent years. Additionally, it provides details on the challenges faced by them in the market.

The major players of the TMS(Transcranial Magnetic Stimulation) Coil market are:

MAG & MoreMagstimMagVentureANT NeuroBrain Latam CoDeymed

Note: Additional or specific companies can be profiled in the list at no extra cost.

Get free sample report @ https://dataintelo.com/request-sample/?reportId=98909

During the preparation of the report, the research team conducted several interviews with key designated executives and experts of the market. This, in turn, has helped them to understand the overall scope and complex matrix of the TMS(Transcranial Magnetic Stimulation) Coil market. The market research report includes crucial data and figures about the report that aids the esteemed reader to make crucial business decisions. These data and figures are added in a concise manner in form of infographics and tables to save time.

TMS(Transcranial Magnetic Stimulation) Coil Market Report Gives Out FREE COVID-19 Chapter

The COVID-19 pandemic had forced government state bodies across the globe to impose lockdown, which in turn, derailed the entire economy. Manufacturing facilities, schools, colleges, and offices witnessed a complete shutdown for few months in 2020. This resulted in the slowdown in the sales of products, which majorly impacted the growth rate of the market. Conversely, new market opportunities were explored and indeed created lucrative opportunities for the industry players.

The COVID-19 chapter covers the impact of pandemic on the market in a detailed manner. This includes product launches and strategies implemented by the industry players in the trying times. It discusses new market avenues, revenue drivers, untapped opportunities, and top-winning strategies in the market.

The research team has monitored the market closely in COVID-19 pandemic and conducted interviews with the market experts to understand the impact of coronavirus pandemic on the TMS(Transcranial Magnetic Stimulation) Coil market. Moreover, the market provides information on the long-term challenges industry players is anticipated to face due to the pandemic.

Buy the complete report @ https://dataintelo.com/checkout/?reportId=98909

In-depth Insights on the Market Segments

The market segmentation are the vital fragments of the market. This report covers the types of the products available in the market, their applications and end-uses. Moreover, it includes the regional landscape of the market.

This part of the report covers the raw materials used for the products, supply & demand scenario, and potential applications of the products in the coming years. The market segmentation also provides in-depth insights on the regional market performance. This means that the regional landscape covers products sales in terms of volume and revenue from 2017 to 2020. Moreover, it provides insights on the expected performance of the product segment during the forecast period.

The global TMS(Transcranial Magnetic Stimulation) Coil report gives in detailed insights on the regional landscape, which involves determining the potential of worth of investment in the particular region/country. Moreover, it gives out information about the market share of the industry players in the particular region.

Products

H-coilC-core CoilCircular Crown Coil

Applications

HospitalClinicOthers

Regions

North AmericaEuropeAsia PacificMiddle East & AfricaLatin America

Note: Country of your choice can be added at no extra cost. However, if one more than country needs to be added in the list, the research quote will vary accordingly.

The complete TMS(Transcranial Magnetic Stimulation) Coil report can be tailored according to the clients requirements.

Below is the TOC of the report:

Executive Summary

Assumptions and Acronyms Used

Research Methodology

TMS(Transcranial Magnetic Stimulation) Coil Market Overview

Global TMS(Transcranial Magnetic Stimulation) Coil Market Analysis and Forecast by Type

Global TMS(Transcranial Magnetic Stimulation) Coil Market Analysis and Forecast by Application

Global TMS(Transcranial Magnetic Stimulation) Coil Market Analysis and Forecast by Sales Channel

Global TMS(Transcranial Magnetic Stimulation) Coil Market Analysis and Forecast by Region

North America TMS(Transcranial Magnetic Stimulation) Coil Market Analysis and Forecast

Latin America TMS(Transcranial Magnetic Stimulation) Coil Market Analysis and Forecast

Europe TMS(Transcranial Magnetic Stimulation) Coil Market Analysis and Forecast

Asia Pacific TMS(Transcranial Magnetic Stimulation) Coil Market Analysis and Forecast

Asia Pacific TMS(Transcranial Magnetic Stimulation) Coil Market Size and Volume Forecast by Application

Middle East & Africa TMS(Transcranial Magnetic Stimulation) Coil Market Analysis and Forecast

Competition Landscape

If you have any doubts regarding the report @ https://dataintelo.com/enquiry-before-buying/?reportId=98909

About DataIntelo

DataIntelo has extensive experience in the creation of tailored market research reports in several industry verticals. We cover in-depth market analysis which includes producing creative business strategies for the new entrants and the emerging players of the market. We take care that our every report goes through intensive primary, secondary research, interviews, and consumer surveys. Our company provides market threat analysis, market opportunity analysis, and deep insights into the current and market scenario.

To provide the utmost quality of the report, we invest in analysts that hold stellar experience in the business domain and have excellent analytical and communication skills. Our dedicated team goes through quarterly training which helps them to acknowledge the latest industry practices and to serve the clients with the foremost consumer experience.

Contact Info:

Name: Alex Mathews

Address: 500 East E Street, Ontario,

CA 91764, United States.

Phone No: USA: +1 909 545 6473

Email:[emailprotected]

Website:https://dataintelo.com

Visit link:

TMS(Transcranial Magnetic Stimulation) Coil Market 2021 Is Rapidly Increasing Worldwide in Near Future | Top Companies Analysis- MAG & More,...

PITTSBURGH April 7, 2021 Maven Machines, a premier fleet management and telematics software company in the commercial trucking and transportation industry, today announces its integration with McLeod Software. Following the recent launch of Maven Workflow, truckload carriers can now send trip assignments via Mavens cloud-based fleet management platform, and drivers can complete their assigned workflow more efficiently with the mobile app. Maven Workflow provides streamlined workflow capabilities in an easy-to-use interface. Additionally, Maven has designed RESTful, https-based APIs that fully integrate with TMS systems at truckload carriers.

As a Certified Integration Partner with McLeod, Maven can now offer the Maven Workflow platform to McLeod customers. Mavens open API suite works in tandem with LoadMasters Symphony Mobile Communications, and the full-circle integration increases functionality for both Maven and McLeod users.

The McLeod integration partnership complements Mavens new workflow platform, which enables the creation of flexible custom forms and unique stop and location-based trip workflows. The workflow products Trip Viewer fleet management portal and accompanying mobile driver app reduces driver training time and enhances the driver experience. Improving driver satisfaction and productivity is top of mind for many fleets; providing fleets with software that empowers rather than hinders drivers is crucial. Managers can also view real-time data and map updates, and the software works in combination with Mavens suite of other fleet and ELD solutions for a unified experience.

Our partnership with McLeod gives more fleets the opportunity to connect their TMS with Mavens flexible workflow and fleet management solution for increased solution interoperability, said Avi Geller, CEO of Maven Machines. By integrating our software solutions, weve managed to make workflow easier for all involved: planners, dispatchers, managers, fleets, and the drivers, themselves. Now, fleets can more easily plan and dispatch trips, onboard new drivers, enable more efficient employees, and meet customer demand, leading to increases in both efficiency and profitability.

Thanks to Maven Workflows intuitive interface and integration capabilities, users can save time with workflow software. Users no longer need to learn complicated new solutions, as Maven integrates seamlessly with transportation management systems, such as McLeods Loadmaster TMS, to provide a more comprehensive operations management option for fleets.

We are pleased to add Maven to the Symphony Mobile Communications suite, said Robert Brothers, VP of Product Development at McLeod Software.Our carrier customers want tightly integrated driver mobile workflow capabilities.LoadMasters operations platform is the perfect solution for those carriers that want complete, accurate and timely information for both the drivers, through workflows like Maven, and front-line operation personnel.McLeod strives to provide the intelligent connections to industry solutions that our customers desire.

This announcement follows Mavens announcement of its new platform, Maven Workflow. To learn more about Maven, please visit http://www.mavenmachines.com. For more information about Mavens partnership with McLeod Software, specifically, please visit http://www.mcleodsoftware.com/certified-partners/.

###

About Maven Machines: Maven Machines is reinventing transportation management. With Mavens powerful, easy-to-use software platform, trucking and transportation fleets leverage mobile cloud and industrial IoT technologies to optimize efficiency, safety, and profitability. Maven utilizes machine learning and data analytics for real-time, automated dispatch, planning, route optimization, workflow, and fleet management solutions. Mavens exponential growth is largely driven by close industry partnerships, empowering fleets to produce measurable results with innovative technological solutions. For more information, please visit mavenmachines.com.

About McLeod Software: McLeod Software provides best in class, comprehensive, transportation and logistics ERP solutions.The companys LoadMaster and PowerBroker products include CRM, dispatch operations, EDI, accounting, billing and settlements, carrier, driver and trip management, business process automation, visual workflow management, and document management systems, all specifically developed for trucking.

Follow this link:

Maven Machines Integrates with McLeod Software to Improve Fleet and Driver Workflow - DC Velocity

I have suffered from Obsessive Compulsive Disorder for 27 years. In the Yale-Brown Obsessive Compulsive Scale Scale, I score in the severe OCD category. For 27 years I have seen one psychiatrist and therapist after another. I have been prescribed every kind of psychiatric medication imaginable, everything from Anafrinil to Zoloft. Nothing has worked.

My OCD has cost me jobs and threatened my marriage and contributed to my divorce.

When I heard about a relatively new therapy for treatment-resistant OCD patients called transmagnetic stimulation (TMS), I was excited. The treatment sounded promising. For the first time in decades there was hope that my days of suffering might soon be over. I am 57. Perhaps I could live my last ten or twenty years free from this terrible disorder.

I saw a doctor at a clinic that provides TMS and he readily agreed that my OCD would benefit from TMS for OCD. The only problem, TMS is not cheap. It is more than $6,000 for one round of treatment (as opposed to, say, $5 for a bottle of Prozac). And it doesnt last forever. You often have to go back for more treatments, sometimes after months, sometimes years.

I have medical insurance, of course. Anthem Blue Cross Blue Shield, a for-profit corporation ranked 29th on the Fortune 500. My employer and I pay a lot for it. However, Anthem and its doctor denied our request for coverage. The reason: While TMS is covered for depression, it is not covered for OCD.

I was confused. The FDA approved TMS for OCD in August 2018. That is nearly three years prior to the time of my request. And yet Anthem Blue Cross Blue Shield is still not covering this treatment, even though it is one of the few things that seems to work for intractable cases of OCD like mine.

Why does it take so long for insurance companies to cover new treatments? I wish I could tell you. I asked Scott Golden, director of corporate communications at Anthem. He did not respond to my emails.

Basically, Anthem Blue Cross Blue Shield is telling me that they are happy to pay for treatments that dont work (like Prozac, Zoloft, etc.), but will not pay for those that do work.

I was not surprised that my request for coverage was rejected. Until ObamaCare, health insurers were notorious for cancelling coverage for people with pre-existing conditions. While the law now bans that practice, Anthem has continued to reject coverage to sick and desperate policy holders. Most famously in May 2014, Anthem Blue Cross refused to pay for the hospitalization of a Sonoma County, Calif. man suffering stage four cancer, although he had paid Anthem more than $100,000 in premiums. After negative news coverage and a subsequent public outcry, guess what? Anthem paid for coverage.

Naturally, Anthem is one of the loudest voices objecting to health care reform.

After our request for coverage was rejected, we got ready to appeal, preparing a letter of medical necessity, requesting ancient medical records, submitting to more tests, anything that might help my case, knowing the appeal too would likely be rejected.

But there wasnt much point to it. Like many companies, the organization I work for changes insurance providers almost as often as we change calendars, as medical costs continue to soar. I was notified recently that my employer is getting a new insurance provider. So, even if I went through the appeals process and won, it would be a waste of time. I will have to start the whole process over with a new health insurance company July 1, and they would doubtless reject coverage too.

Meanwhile, I was wondering whether my familywhich already owes tens of thousands of dollars in medical bills thanks to the many (unrelated) eye surgeries I have hadcan afford to go into even more debt to pay for TMS.

Not surprisingly, all of this began to take a toll on my physical and mental health.

Besides, OCD, I suffer from high blood pressure and anxiety and panic attacks. Eventually the constant stress and frustration of arguing with the health insurance company, the long hours on hold only to be cut off the moment I got a human voice, the constant wild goose chases, and the constant errors made by the health insurance company on documents and forms, proved too much for a person suffering multiple mental and physical health issues.

Ultimately, I decided the fights with the insurance company were not worth it. My anxiety and blood pressure were through the roof and my panic attacks were coming with increasing frequency. I feared Id have a stroke or heart attack if the stress continued.

I told the doctors at the TMS clinic to forget it. No matter how bad the OCD, it wasnt worth dying over.

I suppose this was some kind of victory for the shareholders of Anthem Blue Cross Blue Shield. They saved $6,000.

Thats what Americas health care system is all about after all. Keeping the shareholders happy and flush with cash.

There is a solution, of course. Medicare for All or some form of universal health care like every other developed nation on earth has. But, of course, that wont happen here in the USA. Not in my lifetime. Americans love our insurance companies too much to allow them to become obsolete.

Dont ask me why.

Continued here:

Another Win for Health Insurers, a Big Loss for this Patient - CounterPunch.org - CounterPunch

Industry Growth Insights (IGI) has published a latest report on Global Transcranial Magnetic Stimulators (TMS) Market report. This report has been prepared by primary interviews and secondary research methodology. The market report provides detailed insights on the product pricing & trends, market drivers, and potential lucrative opportunities, during the forecast period, 2020-2027. Additionally, it covers market challenges and threats faced by companies.

Competitive Landscape

The market report provides information about the companys product, sales in terms of volume and revenue, technologies utilized, and innovations carried out in recent years. Additionally, it provides details on the challenges faced by them in the market.

The major players of the Transcranial Magnetic Stimulators (TMS) market are:

YiruideNeuroneticsMagstimBrainswayMagVentureeNeuraRemedNeurosoftDr. Langer MedicalNexstimMAG & More

Note: Additional or specific companies can be profiled in the list at no extra cost.

Get free sample report @ https://industrygrowthinsights.com/request-sample/?reportId=170082

During the preparation of the report, the research team conducted several interviews with key designated executives and experts of the market. This, in turn, has helped them to understand the overall scope and complex matrix of the Transcranial Magnetic Stimulators (TMS) market. The market research report includes crucial data and figures about the report that aids the esteemed reader to make crucial business decisions. These data and figures are added in a concise manner in form of infographics and tables to save time.

Transcranial Magnetic Stimulators (TMS) Market Report Gives Out FREE COVID-19 Chapter

The COVID-19 pandemic had forced government state bodies across the globe to impose lockdown, which in turn, derailed the entire economy. Manufacturing facilities, schools, colleges, and offices witnessed a complete shutdown for few months in 2020. This resulted in the slowdown in the sales of products, which majorly impacted the growth rate of the market. Conversely, new market opportunities were explored and indeed created lucrative opportunities for the industry players.

The COVID-19 chapter covers the impact of pandemic on the market in a detailed manner. This includes product launches and strategies implemented by the industry players in the trying times. It discusses new market avenues, revenue drivers, untapped opportunities, and top-winning strategies in the market.

The research team has monitored the market closely in COVID-19 pandemic and conducted interviews with the market experts to understand the impact of coronavirus pandemic on the Transcranial Magnetic Stimulators (TMS) market. Moreover, the market provides information on the long-term challenges industry players is anticipated to face due to the pandemic.

Buy the complete report @ https://industrygrowthinsights.com/checkout/?reportId=170082

In-depth Insights on the Market Segments

The market segmentation are the vital fragments of the market. This report covers the types of the products available in the market, their applications and end-uses. Moreover, it includes the regional landscape of the market.

This part of the report covers the raw materials used for the products, supply & demand scenario, and potential applications of the products in the coming years. The market segmentation also provides in-depth insights on the regional market performance. This means that the regional landscape covers products sales in terms of volume and revenue from 2017 to 2020. Moreover, it provides insights on the expected performance of the product segment during the forecast period.

The global Transcranial Magnetic Stimulators (TMS) report gives in detailed insights on the regional landscape, which involves determining the potential of worth of investment in the particular region/country. Moreover, it gives out information about the market share of the industry players in the particular region.

Products

STMSPTMSRTMSnTMS

Applications

DepressionTinnitusAlzheimerParkinsons DiseasePsychiatric DisordersHeadacheStroke

Regions

Note: Country of your choice can be added at no extra cost. However, if one more than country needs to be added in the list, the research quote will vary accordingly.

The complete Transcranial Magnetic Stimulators (TMS) report can be tailored according to the clients requirements.

Below is the TOC of the report:

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Transcranial Magnetic Stimulators (TMS) Market Overview

Global Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast by Type

Global Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast by Application

Global Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast by Sales Channel

Global Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast by Region

North America Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast

Latin America Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast

Europe Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast

Asia Pacific Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast

Asia Pacific Transcranial Magnetic Stimulators (TMS) Market Size and Volume Forecast by Application

Middle East & Africa Transcranial Magnetic Stimulators (TMS) Market Analysis and Forecast

Competition Landscape

If you have any doubts regarding the report @ https://industrygrowthinsights.com/enquiry-before-buying/?reportId=170082

About Industry Growth Insights (IGI)

Industry Growth Insights (IGI) has extensive experience in the creation of tailored market research reports in several industry verticals. We cover in-depth market analysis which includes producing creative business strategies for the new entrants and the emerging players of the market. We take care that our every report goes through intensive primary, secondary research, interviews, and consumer surveys. Our company provides market threat analysis, market opportunity analysis, and deep insights into the current and market scenario.

To provide the utmost quality of the report, we invest in analysts that hold stellar experience in the business domain and have excellent analytical and communication skills. Our dedicated team goes through quarterly training which helps them to acknowledge the latest industry practices and to serve the clients with the foremost consumer experience.

Contact Info: Name: Alex MathewsAddress: 500 East E Street, Ontario,CA 91764, United States.Phone No: USA: +1 909 414 1393Email: [emailprotected]Website: https://industrygrowthinsights.com

View post:

Transcranial Magnetic Stimulators (TMS) Market 2021 Is Booming Across the Globe by Share, Size, Growth, Segments and Forecast to 2027 | Top Players...

Global Transportation and Logistics Software Market Research Report 2021

Global Transportation and Logistics Software Market present insights on the current and future industry trends, enabling the readers to identify the products and services, hence driving the revenue growth and profitability. The research report provides a detailed analysis of all the major factors impacting the market on a global and regional scale, including drivers, constraints, threats, challenges, opportunities, and industry-specific trends. Further, the report cites global certainties and endorsements along with downstream and upstream analysis of leading players. The research report comes up with the base year 2021 and the forecast between 2021 and 2027.

Transportation and Logistics Software includes a variety of products aimed at coordinating the physical movement of goods across a companys distribution network. These activities may include:managing freight and shipping costs, meeting service agreements, automated job scheduling and tracking, and optimizing transit time and routes.

The major players covered in Transportation and Logistics Software Markets: TMW, 3G tms, AFS Transportation Management, Avaal, BluJay Solutions, Descartes, FarEye, Llamasoft, LogiNext Mile, Manhattan, Mettler Toledo, Omnitracs Roadnet, Phalanx, ProTransport, Ramco Logistics Software, RouteSmart Technologies, ShipFusion, UltraShipTMS, VIP Delivery, and more

The final report will add the analysis of the Impact of Covid-19 in this report Transportation and Logistics Software industry.

Get a Sample Copy @ https://www.reportsandmarkets.com/sample-request/global-transportation-and-logistics-software-market-size-status-and-forecast-2019-2025?utm_source=soccernurds&utm_medium=42

Drivers and Risks

The report pays special attention to factors which contribute to the Transportation and Logistics Software Market growth also known as market drivers. Any changes in these market dynamics directly affect the market growth hence the report provides a future insight into important factors that should be monitored and which could be leveraged by companies, vendors, distributors and all stakeholders alike to their advantage. The report also provides an insight into the challenges faced by the market and the strategies used by existing players to overcome or avoid these risks.

Segment by Type

Segment by Application

Regional overview

As already mentioned, the report covers different regions such as North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. The different strategies employed by different players in different regions has been studied extensively in order to gain an understanding of the global market. It is important to understand where the Transportation and Logistics Software market has been, currently is and where it is projected to go so that an accurate picture of the future may be painted. Studying the Transportation and Logistics Software market allows an outlook, the latest trends, and prospects in the period of 2021 to be embraced and understood.

Latest industry news

The key players in the global Transportation and Logistics Software market have been busy acquiring startups and participating in collaborations, mergers, and innovations. This report highlights how the most prominent vendors in the market have been contributing to the market. In addition to highlighting the most prominent vendors, the report also takes a look at promising new players in the global Transportation and Logistics Software market.

Key questions answered in the report:

Inquire More about This Report @

https://www.reportsandmarkets.com/enquiry/global-transportation-and-logistics-software-market-size-status-and-forecast-2019-2025?utm_source=soccernurds&utm_medium=42

TheTransportation and Logistics Softwaremarket research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs. These data representations provide predictive data regarding the future estimations for convincing market growth. The detailed and comprehensive knowledge about our publishers makes us out of the box in case of market analysis.

Table of Contents

Chapter 1:GlobalTransportation and Logistics SoftwareMarket Overview

Chapter 2:Transportation and Logistics Software Market Data Analysis

Chapter 3:Transportation and Logistics Software Technical Data Analysis

Chapter 4:Transportation and Logistics Software Government Policy and News

Chapter 5:Global Transportation and Logistics Software Market Manufacturing Process and Cost Structure

Chapter 6:Transportation and Logistics Software Productions Supply Sales Demand Market Status and Forecast

Chapter 7:Transportation and Logistics Software Key Manufacturers

Chapter 8:Up and Down Stream Industry Analysis

Chapter 9:Marketing Strategy -Transportation and Logistics Software Analysis

Chapter 10:Transportation and Logistics Software Development Trend Analysis

Chapter 11:Global Transportation and Logistics Software Market New Project Investment Feasibility Analysis

About Us:

Reports and Marketsis not just another company in this domain but is a part of a veteran group calledAlgoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world. The database of the company is updated on a daily basis. Our database contains a variety of industry verticals that include: Food Beverage, Automotive, Chemicals and Energy, IT & Telecom, Consumer, Healthcare, and many more. Each and every report goes through the appropriate research methodology, Checked from the professionals and analysts.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Continue reading here:

Global Transportation and Logistics Software Market Status Analysis and Forecast 2021-2027 with key player- TMW, 3G tms, AFS Transportation...

CORAL SPRINGS, FL - Many depression sufferers have tried everything.

They've tried anti-depressants...sometimes three or four different kinds.

They've tried traditional "talk" counseling.

Sign Up for Coral Springs Newsletter

Our newsletter delivers the local news that you can trust.

You have successfully signed up for the TAPinto Coral Springs Newsletter.

They've tried following mental health advice.

Theyve listened to their friends and family tell them to just choose to be happy.

But for many people suffering from depression, none of the above have truly helped them find lasting relief.

Until now.

A new form of treatment known as Nexstim TMS Therapy has been clinically proven to be effective at treating depression at its source.

Nexstim TMS Therapy uses magnetic-stimulation to reach the part of the brain that controls whether a person feels happy or sad.

In fact, Nexstim TMS Therapy has been proven to be effective forpatients who didn't respond to traditional depression treatments.

Nexstim TMS therapy can potentially help depression sufferers get off their antidepressants, which is a major plus for many patients.

Nexstim TMS Therapy is:

Safe

FDA-approved

Medication-free

Covered by most insurances

No systemic side effects

Thinking Nexstim TMS Therapy may be the right choice? And want more information?

Heres what to do next:

- Click the link below. Fill out the form (30 seconds). Get Started Here:https://visit.neurowellnesstms.info/survey/

- Schedule a free phone consultation. For faster service, call (954) 945-7222.

More here:

Neuro Wellness TMS Centers of America in Coral Springs: Many Depression Sufferers Have Tried Everything. It's Time To Try Nexstim TMS Therapy. -...

Talk about transcranial magnetic stimulation, or TMS therapy, is raising hopes of parents who wonder if the treatment could work for their child with autism spectrum disorder (ASD).

Parents with children on the spectrum are wary of the term cure. For some, its because theyve been disappointed by snakeoil and false hope more than they care to remember; for others, the term cure seems more fitting to a disease. When you talk with parents of kids on the spectrum, most are willing to do anything to help their children thrive while firmly embracing who he/she is.

And yet, even autistic adults who celebrate the beautiful difference of their minds, admit that certain symptoms associated with autism create difficulties in everyday life. For example, those on the spectrum often have trouble with social situations and communication. Addressing these challenges in a way that embraces who the child is, but modifies behavior to make life easier, seems like a worthy (and lofty!) goal.

Some see transcranial magnetic stimulation (TMS) as a treatment worthy of optimism. While researchers urge caution, studies suggest promise and both diagnostic and therapeutic potential (Oberman et al., 2016).

TMS or transcranial magnetic stimulation, is a treatment that directs recurring magnetic energy pulses at specific regions of the brain involved in mood control. The definition sounds a little frighteningenergy or magnetic pulses entering the brain brings up images of inhumane psych wards in horror movies. But actually the treatment is noninvasive, with relevantly little discomfort, and its helped many patients with debilitating depression.

TMS therapy (or treatment) uses short pulses of magnetic fields to stimulate nerve cells in specific areas of the brain, like the prefrontal cortex which is involved with mood regulation.

When mentioning TMS, people are most familiar with its potential as a treatment for major depressive disorder, but its therapeutic benefits are being investigated for other conditions too. In this regard, researchers believe TMS may possibly alleviate symptoms associated with obsessive compulsive disorder (OCD), autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), anxiety, and posttraumatic stress disorder (PTSD).

When someone undergoes TMS, the person administering (usually a psychiatrist, physician, or sometimes a clinical psychologist) presses a device to the left side of the patients head, and starts the process of moving magnetic fields into the brain with the flip of a switch.

These magnetic fields produce tiny magnetic currents as they move into the brain. The currents activate cells to release neurotransmitters like serotonin and dopamine. The release of these feel-good chemical messengers may restore balance in the brain which may bring relief for those suffering from depression.

As individuals with autism may have low brain serotonin concentrations (Ademsen et al., 2014), its no wonder researchers see promise in the treatment for those with autism spectrum disorder (ASD).

Most doctors state sessions lasting between 30-40 minutes are best, with a recommended 30 sessions over the course of six weeks. Patients usually experience relief (like an elevation in mood) within two to four weeks of the treatment commencing.

Although TMS is FDA approved, this authorization applies to administration in adults (between the ages of 18-70) and only for severe depression that doesnt respond to other medicationsFDA authorisation now applies to other conditions like OCD too. Should a child therefore undergo the treatment for autism, it would be considered off-label.

While TMS may sound good in theory, parents are obviously concerned about any type of therapy administered to their childs brain. However, a study (Yang et al., 2019) reported significant reduction in social and language related symptoms after children with ASD underwent TMS treatment courses. The study also reported possible improvements in cognition and imitation as reported by caregivers. The study saw promise in TMS to improve core deficits in low-functioning children with ASD.

Even though suggestions of success are encouraging, parents also want reassurance that the treatment does not have serious side effects. In addition, parents may wonder about the level of discomfort and the sensory implications of the therapy.

As mentioned, much research is still needed in terms of the application and side effects of TMS, especially when administered to children on the spectrum. In the meantime, studies pertaining to the effects of TMS on neurotypical children may be an appropriate source.

In a study by Krishnan et al. (2014) noninvasive brain stimulation techniques such as TMS were examined to assess the treatments safety when administered to children and adolescents.

The study found repetitive TMS to be safe in children and adolescents when safety guidelines were followed. When side effects were present, it seemed similar to side effects experienced by adults. Out of 513 of the children (or adolescents) involved in the study, 11.5% experienced headaches, 2.5% experienced scalp discomfort, 1.2% experienced twitching, and a very small percentage experienced mood changes, fatigue and tinnitus (Krishnan et al., 2014).

When looking at anecdotal evidence of pain and discomfort experienced, when undergoing TMS treatment, the verdict seems positive. The treatment is generally well tolerated and some feel the lack of serious side effects make it a great alternative for those sensitive to medication.

Parents should, however, be aware of reports of patients experiencing pain, especially at the site of stimulation. Croarkin et al. (2011) detailed the pain experienced (during TMS administration) by two children aged 10, and an adolescent aged 17. The 17-year-old mentioned the pain felt like a headache, sort of like a migraine behind my eyes.

This high level of pain experienced may be rare, but parents of children with ASD should be aware of the worst case scenarioespecially when children with sensory difficulties like tactile defensiveness are involved.

An aspect of TMS that probably needs more investigation, especially for children with autism, is the risk of seizures. As children with autism have a higher chance of being diagnosed with epilepsy too, this concern should be addressed with a qualified professional before deciding on the appropriateness of TMS.

Stultz et al. (2020) produced a literature review of the safety of TMS with respect to seizures and mentions that TMS has been successfully used in patients with epilepsy and traumatic brain injuries. It is further mentioned in the review that seizures are a rare but serious side effect of TMS, but the risk may be low at less than one percent.

There may be further good news, as a new treatment combines TMS with Quantitative Electroencephalogram (qEEG) and Electrocardiogram (ECG/EKG) to deliver a tailored treatment to the patients unique brain pattern.

The fact that this personalized protocol, known as Magnetic e-Resonance Therapy (MeRT), ascertains the individuals brain patterns, means greater success may be achieved in restoring chemical imbalances.

For parents who would like to find out more about MeRT, specifically for a child with ASD, the following story of Frankie (who stopped toe-walking and learned to talk after his family discovered MeRT) will be an inspiring read.

Experts agree that, although TMS and specifically MeRT appear promising, research is urgently needed to establish efficiency and the long term effects of the treatment. Researchers are hopeful that future studies will find proof that TMS and MeRT are effective in treating certain ASD symptoms like social and language deficiencies.

The TMS journey of Kim Hollingsworth Taylor (founder of the Clearly Present Foundation) became an internet cautionary tale for the extreme highs and lows she experienced when her son underwent TMS. The treatment relieved some of her sons autistic symptomsbut only temporarily. This only highlights the fact that more research is needed, especially concerning long-term outcomes of TMS.

When a study (Sokhadze et al. 2018) lists significant improvements in measures of executive functions and behavior in kids with autism, parents may rightfully experience a surge of hope. Researchers do urge caution, however, as the one thing they seem to agree on is that many more clinical trials and studies are needed to establish the effectiveness of TMS for core symptoms of ASD.

If youve read the research and you believe your child may benefit from TMS or MeRT, the best course of action would be to see your physician or a psychiatrist. These medical professionals will take your childs medical history (and conditions like epilepsy) into consideration before helping you decide if it is the right course of action for your child.

References:

Adamsen, D., Ramaekers, V., Ho, H.T. et al. (2014). Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene. Molecular Autism 5, 43. https://doi.org/10.1186/2040-2392-5-43

Coarkin, P. E., Wall, C. A., King, J. D., Andrew Kozel, F., & Daskalakis, Z. J. (2011). Pain during transcranial magnetic stimulation in youth. Innovations in clinical neuroscience, 8(12), 1823.

Krishnan, C., Santos, L., Peterson, M. D., & Ehinger, M. (2015). Safety of noninvasive brain stimulation in children and adolescents. Brain stimulation, 8(1), 7687. https://doi.org/10.1016/j.brs.2014.10.012.

Oberman, L. M., Rotenberg, A., & Pascual-Leone, A. (2015). Use of transcranial magnetic stimulation in autism spectrum disorders. Journal of autism and developmental disorders, 45(2), 524536. https://doi.org/10.1007/s10803-013-1960-2

Sokhadze, E. M., Lamina, E. V., Casanova, E. L., Kelly, D. P., Opris, I., Tasman, A., & Casanova, M. F. (2018). Exploratory Study of rTMS Neuromodulation Effects on Electrocortical Functional Measures of Performance in an Oddball Test and Behavioral Symptoms in Autism. Frontiers in systems neuroscience, 12, 20. https://doi.org/10.3389/fnsys.2018.00020

Stultz DJ, Osburn S, Burns T, Pawlowska-Wajswol S, Walton R. Transcranial Magnetic Stimulation (TMS) Safety with Respect to Seizures: A Literature Review. Neuropsychiatr Dis Treat. 2020;16:2989-3000https://doi.org/10.2147/NDT.S276635.

Yang, Y., Wang, H., Xue, Q., Huang, Z., & Wang, Y. (2019). High-Frequency Repetitive Transcranial Magnetic Stimulation Applied to the Parietal Cortex for Low-Functioning Children With Autism Spectrum Disorder: A Case Series. Frontiers in psychiatry, 10, 293. https://doi.org/10.3389/fpsyt.2019.00293.

Read the original post:

TMS Treatment for Autism: What is it and Does it Work? - Autism Parenting Magazine

Jennifer Barredo

The use of transcranial magnetic stimulation (TMS) has a modest yet promising history in suicide reduction, according to the authors of a study published in Neuromodulation.

In this seedbased functional connectivity analysis, Jennifer Barredo et al evaluated whether changes in frontostriatal functional connectivity would accompany suicidality reductions following TMS, with the aim of optimising future treatment. This study was a secondary analysis of an open-label trial of 5Hz TMS of the left dorsolateral prefrontal cortex (DLPFC) in patients with post-traumatic stress disorder (PTSD) and major depressive disorder (MDD).

A total of 25 participants were included in this secondary study. For inclusion in the parent study, participants were required to meet criteria from the Diagnostic and Statistical Manuel of Mental Disorders, fifth edition (DSM-V) for both PTSD and MDD. Patients overall illness severity rating were at least moderately ill on the clinical global impressions-severity scale for each diagnosis. However, actively suicidal intent and suicidal planning were exclusionary.

Patients received eight weeks of 5Hz TMS on the left DLPFC. Clinical symptoms were measured on the Inventory of Depressive Symptomatology-Self Report (IDS-SR) and the PTSD checklist from the DSM-V (PCL-5). Investigators derived their definition of suicidality from IDSSR item 18, which is a thoughts-of-suicide item. Possible responses to item 18 include: (0) no thoughts of death or suicide, (1) feeling that life is empty or wondering if it is worth living, (2) thinking of suicide or death several times a week for several minutes, or (3) thinking of suicide or death in detail multiple times each day, having a specific suicide plan, or having made an attempt.

Functional magnetic resonance imaging (fMRI) was collected before TMS, and at the treatment endpoint. Researchers entered these data into analyses of covariance, evaluating the effect of suicidality change across treatment on striatal and thalamic functional connectivity. Changes in other PTSD and depression symptoms were included as covariates, and results were corrected for multiple comparisons.

Suicidal ideation of any severity was reported by 68% of participants at study baseline, with 10 participants reporting a score of one, five participants reporting a score of two, and two participants reporting a score of three. Researchers found that after TMS, suicidality decreased by a minimum of one point in 65% of participants. However, they did also see an increase of suicidality in 12% of patients, including on one participant who did not endorse suicidality at baseline. Across participants, the mean change in overall PCL-5 and IDSSR scores was 41.8% and 42.6%, respectively, in this subset of the original study cohort. In the parent sample, the average decrease in PCL5 was 35.5% and IDSSR was 37.6%.

In their conclusion, the studys authors commented: Collectively, findings argue that the precise targeting of frontopolar circuits via diffusionguided individualised targeting may enhance neuromodulation delivery precision to our highestrisk patients. Combing these methodologies with innovations in 5Hz TMS delivery, such as pulse energy optimisation, may further improve its efficacy as an antisuicidal treatment.

Visit link:

Repetitive TMS demonstrates ability to reduce suicidal thoughts and behaviours - NeuroNews International

A rating of 95 puts Edap Tms SA (EDAP) near the top of the Healthcare sector according to InvestorsObserver.

Edap Tms SA's score of 95 means that it ranks higher than 95% of stocks in the sector. In addition, its overall score of 93 ranks it higher than 93% of all stocks.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style.

Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Edap Tms SA (EDAP) stock is trading at $9.01 as of 1:24 PM on Monday, Apr 5, an increase of $0.44, or 5.13% from the previous closing price of $8.57. The stock has traded between $8.43 and $9.20 so far today. Volume today is low. So far 171,165 shares have traded compared to average volume of 321,075 shares.

Click Here to get the full Stock Score Report on Edap Tms SA (EDAP) Stock.

See the original post:

Can Edap Tms SA (EDAP) Stock Rise to the Top of Healthcare Sector Monday? - InvestorsObserver

The Transcranial Magnetic Stimulators (TMS) market is expected to grow at a CAGR of 7.7% and is poised to reach $XX Billion by 2027 as compared to $XX Billion in 2020. The factors leading to this extraordinary growth is attributed to various market dynamics discussed in the report. Our experts have examined the market from a 360 degree perspective thereby producing a report which is definitely going to impact your business decisions.In order to make a pre-order inquiry, kindly click on the link below:-https://decisivemarketsinsights.com/transcranial-magnetic-stimulators-tms-market-research-report-2025/84077853/pre-order-enquiry

Transcranial Magnetic Stimulators (TMS) Market Summary and Growth Forecast

The report by Decisive Market Insights contains all the latest data and structures related to the industry. Also, the current market trends, as well as the future market trends, are highlighted in the report. This newly added research report on this industry is a complete guide to all the companies in this field. The report is built and produced in such a manner that will help the customers to understand several factors and pointers about the growth progression of this industry. The report will overall help the companies to grow and to make higher profits in the future. Thus better strategies are mentioned and recommended by the experts in the report.

To avail Sample Copy of report, visit @ https://decisivemarketsinsights.com/transcranial-magnetic-stimulators-tms-market-research-report-2025/84077853/request-sample

Global Transcranial Magnetic Stimulators (TMS) Market: Product Segment AnalysisSTMSPTMSRTMSnTMSGlobal Transcranial Magnetic Stimulators (TMS) Market: Application Segment AnalysisDepressionTinnitusAlzheimerParkinsons DiseasePsychiatric DisordersHeadacheThe Players mentioned in our report

YiruideNeurosoftNeuroneticsRemedMagstimNexstimeNeuraMagVentureDr. Langer MedicalBrainswayMAG& More

A full review of the top players of the industry is mentioned. Thus a brief analysis of the key players of the industry with their market strategies is elaborately explained and described. An adequate amount of data is given and explained with figures and diagrams for easy understanding. The report is designed in such a way that it can help the decision-makers of the company to make proper decisions at the right time and can achieve better results. The report also motivates and influences investors to make smart investments wisely. The report will also be helpful for the companies who want to penetrate the market. These companies can easily penetrate the market by applying some specific strategies that are given and well explained in the report as well.

To inquire about the discount, kindly fill the form by clicking on the link below:-https://decisivemarketsinsights.com/transcranial-magnetic-stimulators-tms-market-research-report-2025/84077853/request-discount

The report on this market is a comprehensive study of the current and latest facts about the industry. The study also deals with the global position and the status of the top companies that are ruling in the current market related to this industry. The current market is the most promising and booming sector in the industry. The demand for the products and services is rising vastly and on a global basis as well. So the demand for this market will be there in the future and thus the companies can enjoy higher returns on a long-term basis. The research study also offers a wide analysis of the vital aspects of the market such as segmentation, competition, manufacturing cost analysis, geographical process, and price structures. The report has also provided the number of sales, volumes, production rates, revenues, and other estimations that are well involved in the market regarding the industry.

Kindly contact us and our expert will get back to you within 30 minutes:

Decisive Markets InsightsSunil KumarSales HeadEmail [emailprotected]US +18317045538UK +441256636046

Read the original post:

Transcranial Magnetic Stimulators (TMS) Market is Expected to Grow with an Impressive CAGR till 2027 | Players Yiruide Neurosoft Neuronetics KSU |...